Meeting Banner
Abstract #4851

Quantitative T2 Mapping in Advanced Cervical Cancer: A Pilot Study of Patients’ Concurrent Chemoradiotherapy Response

Shujian Li1, Jie Liu1, Jinxia Zhu2, Han Fei3, and Jingliang Cheng1
1Department of Magnetic Resonance, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China, 2MR Collaboration, Siemens Healthcare Ltd, Beijing, China, 3MR R&D Collaboration, Siemens Healthineers, Los Angeles, CA, United States

This study determined the value of quantitative transverse relaxation time (T2) mapping as an alternative method to conventional magnetic resonance imaging (MRI) for evaluating the response to concurrent chemoradiotherapy (CCRT) in 27 patients with advanced cervical cancer (CC). Response values were calculated at three time points (before CCRT, 4 weeks after CCRT, and at the end of CCRT) and then compared. The results showed that quantitative T2 mapping can be effectively used for monitoring treatment response during and after treatment, but not for pre-treatment monitoring.

This abstract and the presentation materials are available to 2020 meeting attendees and eLibrary customers only; a login is required.

Join Here